These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24964806)

  • 1. Type I interferon mimetics bypass vaccinia virus decoy receptor virulence factor for protection of mice against lethal infection.
    Ahmed CM; Johnson HM
    Clin Vaccine Immunol; 2014 Aug; 21(8):1178-84. PubMed ID: 24964806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN mimetic as a therapeutic for lethal vaccinia virus infection: possible effects on innate and adaptive immune responses.
    Ahmed CM; Martin JP; Johnson HM
    J Immunol; 2007 Apr; 178(7):4576-83. PubMed ID: 17372016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.
    Ahmed CM; Burkhart MA; Subramaniam PS; Mujtaba MG; Johnson HM
    J Virol; 2005 May; 79(9):5632-9. PubMed ID: 15827178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections.
    Ahmed CM; Johnson HM
    J Interferon Cytokine Res; 2014 Oct; 34(10):802-9. PubMed ID: 24811478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2.
    Liptáková H; Kontseková E; Alcamí A; Smith GL; Kontsek P
    Virology; 1997 May; 232(1):86-90. PubMed ID: 9185591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.
    Ahmed CM; Dabelic R; Martin JP; Jager LD; Haider SM; Johnson HM
    J Immunol; 2010 Jul; 185(2):1103-13. PubMed ID: 20543109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.
    Alcamí A; Symons JA; Smith GL
    J Virol; 2000 Dec; 74(23):11230-9. PubMed ID: 11070021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain.
    Cao H; Dai P; Wang W; Li H; Yuan J; Wang F; Fang CM; Pitha PM; Liu J; Condit RC; McFadden G; Merghoub T; Houghton AN; Young JW; Shuman S; Deng L
    PLoS One; 2012; 7(5):e36823. PubMed ID: 22606294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon α/β Decoy Receptor Encoded by a Variant in the Dryvax Smallpox Vaccine Contributes to Virulence and Correlates with Severe Vaccine Side Effects.
    Liu R; Americo JL; Earl PL; Villani J; Cotter CA; Moss B
    mBio; 2022 Feb; 13(1):e0010222. PubMed ID: 35189701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.
    Dai P; Cao H; Merghoub T; Avogadri F; Wang W; Parikh T; Fang CM; Pitha PM; Fitzgerald KA; Rahman MM; McFadden G; Hu X; Houghton AN; Shuman S; Deng L
    J Virol; 2011 Oct; 85(20):10814-25. PubMed ID: 21835795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins.
    Bandi P; Pagliaccetti NE; Robek MD
    J Interferon Cytokine Res; 2010 Mar; 30(3):123-34. PubMed ID: 20038204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response.
    White SD; Jacobs BL
    J Virol; 2012 May; 86(10):5895-904. PubMed ID: 22419806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.
    Waibler Z; Anzaghe M; Frenz T; Schwantes A; Pöhlmann C; Ludwig H; Palomo-Otero M; Alcamí A; Sutter G; Kalinke U
    J Virol; 2009 Feb; 83(4):1563-71. PubMed ID: 19073732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses.
    Hwang M; Bergmann CC
    J Virol; 2018 May; 92(10):. PubMed ID: 29491163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interferon system and vaccinia virus evasion mechanisms.
    Perdiguero B; Esteban M
    J Interferon Cytokine Res; 2009 Sep; 29(9):581-98. PubMed ID: 19708815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system.
    Ahmed CM; Dabelic R; Waiboci LW; Jager LD; Heron LL; Johnson HM
    J Virol; 2009 Feb; 83(3):1402-15. PubMed ID: 19019946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
    Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
    J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection.
    Reading PC; Symons JA; Smith GL
    J Immunol; 2003 Feb; 170(3):1435-42. PubMed ID: 12538705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection.
    Benfield CTO; Ren H; Lucas SJ; Bahsoun B; Smith GL
    J Gen Virol; 2013 Jul; 94(Pt 7):1647-1657. PubMed ID: 23580427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.